Ariel Gruswitz, JD, has joined Facility Logix as associate director. She will be responsible for leading the firm’s consulting services practice and expanding its Feasibility and Market Analysis capabilities.
BioHealth Innovation Inc. (BHI) announces the addition of Diane Ignar, Ph.D., and Dr. Loleta Robinson to the expanding Entrepreneurs-in-Residence (EIR) team. The Entrepreneur-in-Residence Program at BHI ensures that disruptive technologies receive all the resources required to transform the technology from a discovery into a commercially relevant product and eventually have a measurable impact on human health. The program was created to support scientists, early-stage startups, and licensed technologies to provide them with access to these resources. Diane will work with NIH’s National Institute on Aging, and Loleta will work with their Office of Extramural Research.
Arcellx, a privately held clinical-stage biopharmaceutical company, announced the addition of Kate Aiken as Chief People Officer. Kate is an accomplished human resources business leader who brings more than 20 years of cross-industry experience, building and managing high caliber HR organizations and partnering with business leaders to support the growth of industry leading companies.
MITRE has named Dr. Jim Pannucci as Managing Director for Life Sciences Market Strategy, where he and his team are building an enduring line of life sciences capabilities that enable future health technologies and address unmet medical needs. Pannucci is responsible for focusing on conducting proof of concept studies, creating prototypes, applying new technologies, and closing critical knowledge gaps in the life sciences with emphasis on HHS and other USG priorities in biological sciences, medicine, preparedness, and bio-surveillance.
ATCC, the world’s premier biological materials management and standards organization, today announced the expanded role of Ruth Cheng, Ph.D., Chief Strategy and Innovation Officer to include duties as Vice President of Corporate Development.
Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced the appointment of Michael S. Hanna, MD, FACC, as chief medical officer.
The Maryland Department of Commerce has appointed Margia Argüello as Sr. Business Development Manager, BioHealth and Life Sciences, Office of Strategic Industries and Entrepreneurship. She has been tasked with cultivating and coordinating opportunities to expand, retain, and attract biohealth and life sciences businesses in Maryland. This includes the development and implementation of programs and initiatives to address the needs of the industry, such as talent attraction and workforce development; capital investment activity expansion; as well as technology transfer and commercialization strategies. Margia will also be working closely with entrepreneurs, start-ups, and early-stage life sciences companies to navigate the resources available to them throughout the Maryland life sciences ecosystem.
The Office of the County Executive at Montgomery County, Maryland recently announced the appointment of Judy Costello as Special Projects Manager. As Special Projects Manager, Judy supports a wide range of business and economic development-related projects (i.e., business/large employer recruitment and retention, education and workforce, small business and innovation, climate change, and transportation). Her focus covers multiple industries within the County.